PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 61 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,597,000 | +25.3% | 66,245 | 0.0% | 0.06% | +31.8% |
| Q1 2017 | $1,275,000 | +25.0% | 66,245 | 0.0% | 0.04% | +7.3% |
| Q4 2016 | $1,020,000 | +18.3% | 66,245 | 0.0% | 0.04% | +5.1% |
| Q3 2016 | $862,000 | -6.4% | 66,245 | 0.0% | 0.04% | -18.8% |
| Q2 2016 | $921,000 | -51.4% | 66,245 | -47.0% | 0.05% | -61.9% |
| Q1 2016 | $1,896,000 | -20.0% | 125,004 | 0.0% | 0.13% | -16.6% |
| Q4 2015 | $2,371,000 | -0.2% | 125,004 | 0.0% | 0.15% | -3.2% |
| Q3 2015 | $2,375,000 | -47.0% | 125,004 | -28.1% | 0.16% | -33.3% |
| Q2 2015 | $4,481,000 | -17.6% | 173,892 | 0.0% | 0.23% | -4.9% |
| Q1 2015 | $5,436,000 | -18.9% | 173,892 | -0.0% | 0.25% | -24.3% |
| Q4 2014 | $6,704,000 | – | 173,894 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |